|
RAB7A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.693030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.931230E-01 |
| Normal-vs-Stage2 |
2.321600E-01 |
| Normal-vs-Stage3 |
6.480000E-01 |
| Normal-vs-Stage4 |
1.281200E-01 |
| Stage1-vs-Stage2 |
7.156800E-01 |
| Stage1-vs-Stage3 |
4.228400E-01 |
| Stage1-vs-Stage4 |
4.554000E-01 |
| Stage2-vs-Stage3 |
3.888400E-01 |
| Stage2-vs-Stage4 |
7.790600E-01 |
| Stage3-vs-Stage4 |
2.275600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.878000E-01 |
| Normal-vs-AfricanAmerican |
1.936770E-01 |
| Normal-vs-Asian |
2.271200E-01 |
| Caucasian-vs-AfricanAmerican |
4.819200E-01 |
| Caucasian-vs-Asian |
4.871800E-01 |
| AfricanAmerican-vs-Asian |
8.952000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.737000E-01 |
| Normal-vs-Female |
1.038250E-01 |
| Male-vs-Female |
2.027400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464580E-01 |
| Normal-vs-Age(41-60Yrs) |
3.048800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.137400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.522000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.757400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.951200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.938560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.504000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.849400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.581600E-02 |
| Classical-VS-Follicular |
9.799800E-01 |
| Classical-VS-Other |
8.971800E-01 |
| Classical-VS-Normal |
2.271200E-01 |
| Tall-VS-Follicular |
1.837420E-01 |
| Tall-VS-Other |
5.061600E-01 |
| Tall-VS-Normal |
1.685510E-02 |
| Follicular-VS-Other |
9.183800E-01 |
| Follicular-VS-Normal |
2.798200E-01 |
| Other-VS-Normal |
4.836200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.259200E-01 |
| Normal-vs-N1 |
7.979000E-01 |
| N0-vs-N1 |
8.224000E-01 |
|
|
